cytotoxic T lymphocyte associated antigen 4 gene polymorphism in type 1 diabetes mellitus
• 2014
Publication Information
Authors
dr sheren mohamed emam, dr neven tawfiq abed, dr sahar yassin mohamed
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
ABSTRACT
This work aimed to Detect Cytotoxic T Lymphocyte-associated antigen 4 (CTLA-4) gene polymorphism in patients with type 1 diabetes mellitus using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to clarify its role in the susceptibility to type 1 diabetes mellitus. The study was carried out on Forty unrelated Egyptian children with clinically suggestive symptoms and signs of Type 1Diabetes Mellitus (T1DM) (Polyurea , Polydypsia, Polyphagia, history of insulin treatment to control hyperglycemia). Twenty unrelated healthy children matched with patients in age and sex were enrolled in this study as a control group; They had no family history of T1DM or other autoimmune disease. Blood samples were collected from patients and control group aseptically and stored at -20°C until further processing. Typing of cytotoxic T Lymphocyte-associated antigen 4 (CTLA-4)gene polymorphism was done using polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP).CTLA-4 G allele and GG homozygous genotype were significantly increased in T1DM patients than in control group (P
This work aimed to Detect Cytotoxic T Lymphocyte-associated antigen 4 (CTLA-4) gene polymorphism in patients with type 1 diabetes mellitus using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to clarify its role in the susceptibility to type 1 diabetes mellitus. The study was carried out on Forty unrelated Egyptian children with clinically suggestive symptoms and signs of Type 1Diabetes Mellitus (T1DM) (Polyurea , Polydypsia, Polyphagia, history of insulin treatment to control hyperglycemia). Twenty unrelated healthy children matched with patients in age and sex were enrolled in this study as a control group; They had no family history of T1DM or other autoimmune disease. Blood samples were collected from patients and control group aseptically and stored at -20°C until further processing. Typing of cytotoxic T Lymphocyte-associated antigen 4 (CTLA-4)gene polymorphism was done using polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP).CTLA-4 G allele and GG homozygous genotype were significantly increased in T1DM patients than in control group (P
Staff Members - Benha University